# Targeted Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/targeted-oncology/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 4,390 |
| Citations | 27,143 |
| h-index | 73 |
| Homepage | https://www.springer.com/journal/11523 |
| Open Access | false |
| ISSN-L | 1776-2596 |
| ISSNs | 1776-2596,1776-260X |
| OpenAlex ID | https://openalex.org/S163958984 |
| Publisher | Adis, Springer Healthcare |
| Works | 1,231 |

## Journal papers

- [Renal Toxicities of Targeted Therapies](https://scholariq.org/papers/renal-toxicities-of-targeted-therapies/)
- [Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management](https://scholariq.org/papers/immune-checkpoint-inhibitor-induced-colitis-diagnosis-and-management/)
- [Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma](https://scholariq.org/papers/comparison-of-acute-toxicity-and-mortality-after-two-different-dosing-regimens/)
- [TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting](https://scholariq.org/papers/trk-fusion-cancer-patient-characteristics-and-survival-analysis-in-the-real/)
- [Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib](https://scholariq.org/papers/clinical-modality-of-resistance-and-subsequent-management-of-patients-with/)
- [Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo](https://scholariq.org/papers/afatinib-efficacy-against-squamous-cell-carcinoma-of-the-head-and-neck-cell/)
- [Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study](https://scholariq.org/papers/histomolecular-resistance-mechanisms-to-first-line-osimertinib-in-egfr-mutated/)

## Journal top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.